Search results for "Infectious diseases"
Progress and limitations on vaccines, strokes and readmissions in COVID-19
A report warned that a few health care workers developed COVID-19 shortly after vaccination, and studies showed that strokes were rare in COVID-19 patients but readmissions could not be predicted easily.
https://immattersacp.org/weekly/archives/2021/02/09/1.htm
9 Feb 2021
ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions’
The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.
https://immattersacp.org/weekly/archives/2022/10/18/5.htm
18 Oct 2022
Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020
CDC issues interim guidance on evaluation, treatment of suspected vaping injuries
The evaluation of patients with suspected e-cigarette, or vaping, product use-associated lung injury (EVALI) should include pulse oximetry, chest X-ray, and, in some cases, chest CT, the CDC advised.
https://immattersacp.org/weekly/archives/2019/10/22/2.htm
22 Oct 2019
New research adds to data on symptoms after COVID-19, vaccines' effects
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://immattersacp.org/weekly/archives/2021/05/25/1.htm
25 May 2021
Oral lefamulin noninferior to oral moxifloxacin in treating community-acquired bacterial pneumonia
Approved by the FDA in August, lefamulin is an “important addition to the current antibiotic armamentarium,” although barriers to use will likely include cost and tolerability concerns, an editor's note said.
https://immattersacp.org/weekly/archives/2019/10/01/2.htm
1 Oct 2019
CDC issues interim guidance on measles infection control and prevention in health care
New government guidance covers what is acceptable evidence of immunity to measles and how to respond if health care personnel are exposed to the disease.
https://immattersacp.org/weekly/archives/2019/07/30/4.htm
30 Jul 2019
Antivirals plus antibiotics may lower risk of hospitalization in some patients with influenza
Although combination antiviral and antibiotic therapy was associated with a significant reduction in respiratory hospitalization risk within 30 days compared to an antiviral alone in this study, that does not mean the combination should be widely used, the authors noted.
https://immattersacp.org/weekly/archives/2020/02/04/2.htm
4 Feb 2020
COVID-19 research covers taste and smell alterations, incidence in nursing homes and shelters, resource allocation policies
Other topics of note this week include guidance from the Infectious Diseases Society of America (IDSA) on personal protective equipment, plus information from the FDA and IDSA on serum antibody tests.
https://immattersacp.org/weekly/archives/2020/04/28/1.htm
28 Apr 2020
Joint guidelines on Lyme disease prevention, diagnosis, treatment open for comment
Among other recommendations, the draft guidelines favor oral antibiotic therapy with doxycycline, amoxicillin, cefuroxime axetil, or phenoxymethylpenicillin over other antimicrobials for treatment of Lyme disease.
https://immattersacp.org/weekly/archives/2019/07/02/2.htm
2 Jul 2019